Published 2012
| Version v1
Publication
Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients.
Additional details
- URL
- http://hdl.handle.net/11567/890380
- URN
- urn:oai:iris.unige.it:11567/890380
- Origin repository
- UNIGE